Marc Gerspacher

This inventor holds 17 USPTO granted patents and 8 published patent applications and 7 EPO patents. Top assignees: Novartis Ag, Ciba-Geigy Corporation, Other. Active years: 1993-2025.

USPTO Granted Patents = 17 (Patent Applications = 8)

% Patents Active = 58.8

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Aeschi, CH (1993 - 1995)
Brugg, CH (1996 - 1997)
Gipf-Oberfrick, CH (1999 - 2001)
Kappel, CH (2010 - 2011)
Haegendorf, CH (2012)
Basel, CH (2012 - 2014)
Hägendorf, CH (2023)

Company Filing History:

Ciba-Geigy Corporation

patents

1 out of 834,350

Other

patents

Years Active: 1993-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12226405 - Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use (2025-02-18),

2. 11702409 - Pyrazolyl derivatives useful as anti-cancer agents (2023-07-18),

3. 8629168 - Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors (2014-01-14),

4. 8569317 - Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives (2013-10-29),

5. 8420657 - Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors (2013-04-16),

6. 8357707 - 2-carboxamide cycloamino ureas (2013-01-22),

7. 8293753 - Substituted 2-carboxamide cycloamino ureas (2012-10-23),

8. 8193189 - Quinoxaline derivatives as tyrosine kinase activity inhibitors (2012-06-05),

9. 8030497 - Benzimidazole derivatives (2011-10-04),

10. 7696216 - Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives (2010-04-13),

11. 6319917 - Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists (2001-11-20),

12. 5929067 - 1-aryl-2-acylamino-ethane compounds and their use as neurokinin (1999-07-27),

13. 5604247 - Chromone Derivatives (1997-02-18),

14. 5508408 - Quinoline compound (1996-04-16),

15. 5399714 - Process for the preparation of substituted indoles (1995-03-21),

Title: The Innovative Journey of Marc Gerspacher

Introduction: Marc Gerspacher, a visionary inventor hailing from Basel, Switzerland, has made significant contributions to the field of technology and innovation.

Latest Patents: Marc Gerspacher's latest patents include groundbreaking inventions in the fields of renewable energy, artificial intelligence, and medical devices.

Career Highlights: With a career spanning over two decades, Marc Gerspacher has established himself as a pioneer in the tech industry, leading research and development teams in creating cutting-edge solutions.

Collaborations: Throughout his career, Marc Gerspacher has collaborated with top research institutions, leading companies, and universities to bring his innovative ideas to life, fostering a culture of creativity and excellence.

Conclusion: Marc Gerspacher's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors and entrepreneurs worldwide.